top of page
Our pen is uncapped and ready to spill.
Hot Off the Pen
Welcome to our blog.
We write about marketing, writing, and whatever else we can fit in the margins.
If you ever have any questions, we always have answers at hello@borrowedpen.com
A $19 Billion MedTech Investment Signals a New Era for Domestic Manufacturing
Becton Dickinson's latest U.S. manufacturing commitment could create new opportunities for medical device suppliers, contract manufacturers, and the marketers who help them win business.
Natalie Hussey
10 min read
FDA's READI-Home Innovation Challenge Signals A Bigger Shift Toward At-Home MedTech
The FDA's READI-Home Innovation Challenge may look like regulatory news. However, MedTech marketing teams should pay closer attention.
Borrowed Pen
4 min read
Marketing Medical Technology In 2026: The Communication Burden Is Accelerating As Fast As The Innovation
Medical technology has always been difficult to market well. The sector sits at the intersection of engineering, clinical science, and regulatory affairs. A product can be technically excellent, clinically validated, and legally marketable yet still struggle to gain adoption. In 2026, that problem is becoming more pronounced.
Borrowed Pen
5 min read
What MedTech Marketers Can Learn from GE HealthCare’s $5.3 Billion Q2
GE Healthcare reports revenue reached $5.3B, up 5.7% YoY, while organic revenue grew 3.5%.
Natalie Hussey
6 min read
The FDA’s New Human Factors Guidance Makes Usability Part Of The Product Story
Medical-device teams have traditionally treated human factors as a regulatory requirement. However, they also provide deep commercial insights.
Natalie Hussey
8 min read
The FDA’s PreCheck Pilot Program And The New Marketing Mandate For Domestic Pharma Manufacturing
On June 29, 2026, the FDA selected seven companies for the first cohort of its PreCheck Pilot Program, a new initiative designed to support the development of domestic pharmaceutical manufacturing facilities.
Natalie Hussey
8 min read
The FDA’s TAP Pilot Shows Why Medical-Device Commercialization Must Begin Before Clearance
The FDA’s latest expansion of its Total Product Life Cycle Advisory Program (TAP) should get the attention of more than regulatory teams. The updates also impact sales and marketing.
Natalie Hussey
7 min read
Medical Device Premarketing Strategy: Building Clinical Credibility During Without Commercial Claims
Premarketing exists within clearly defined regulatory guardrails. In the United States, the Food and Drug Administration (FDA) governs device promotion under frameworks that restrict how investigational or uncleared devices are discussed publicly.
Borrowed Pen
4 min read
Featured Posts
About Borrowed Pen
Topics
Categories
bottom of page